Live Breaking News & Updates on Rafael Amado|Page 7
Stay updated with breaking news from Rafael amado. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Allogene Therapeutics Shares Rise 9% After FDA Approves Trial for Lymphoma morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Allogene FDA Grants RMAT Designation to Allogene's ALLO-501A for Large B Cell Lymphoma globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) have earned a consensus recommendation of “Buy” from the fifteen ratings firms that are presently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 12-month price […] ....
Research analysts at Robert W. Baird started coverage on shares of Allogene Therapeutics (NASDAQ:ALLO – Get Rating) in a research report issued on Thursday, The Fly reports. The brokerage set a “neutral” rating on the stock. Several other equities research analysts also recently issued reports on the company. Raymond James dropped their price objective on […] ....
Analysts expect Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) to report ($0.61) earnings per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Allogene Therapeutics’ earnings. The highest EPS estimate is ($0.59) and the lowest is ($0.67). Allogene Therapeutics reported earnings per share of ($0.53) in the same quarter […] ....